ANNUAL STABILITY TESTING. Patheon and lndivior will agree in writing on any stability testing to be performed by Patheon on the Products. This agreement will specify the commercial and Product stability protocols applicable to the stability testing and the fees payable by lndivior for this testing including the Price for the Product withdrawn for the stability testing. SCHEDULE D ACTIVE MATERIALS Active Materials Supplier Risperidone [***]
ANNUAL STABILITY TESTING. Patheon and Client will agree in writing on any stability testing to be performed by Patheon on the Products. The said agreement will specify the commercial and Product stability protocols applicable to the stability testing and the fees payable by Client for this testing.
ANNUAL STABILITY TESTING. Patheon and Client will agree in writing on any stability testing to be performed by Patheon on the Products. The Quality Agreement will specify the commercial and Product stability protocols applicable to the stability testing and the fees payable by Client for this testing including the Price for the Product withdrawn for the stability testing. THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. SCHEDULE D ACTIVE MATERIALS Active Materials Supplier ptk0796 [* * *]
ANNUAL STABILITY TESTING. 1. Zalviso 2017 Stability Pricing [*]
ANNUAL STABILITY TESTING. Patheon and Client will agree in writing on any stability testing to be performed by Patheon on the Products. This agreement will specify the commercial and Product stability protocols applicable to the stability testing and the fees payable by Client for this testing. [*CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK ***, HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.] SCHEDULE D *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** [*CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK ***, HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.] SCHEDULE E TECHNICAL DISPUTE RESOLUTION Technical Disputes which cannot be resolved by negotiation as provided in Section 12.2 will be resolved in the following manner:
ANNUAL STABILITY TESTING. Supplier and Supernus will agree in writing on any stability testing to be performed by Supplier on the Products, if applicable. Such agreement will specify the commercial and Product stability protocols applicable to the stability testing and the fees payable by Supernus for this testing. SCHEDULE D API API Supplier Oxcarbazepine ** ACTIVE MATERIALS CREDIT VALUE The Active Materials Credit Value will be as follows: PRODUCT API ACTIVE MATERIALS CREDIT VALUE TBD Oxcarbazepine Supernus’ actual cost for API not to exceed ** per kilogram MAXIMUM CREDIT VALUE Supplier’s liability for API calculated in accordance with Section 8 of the Agreement for any Product in a Year will not exceed, in the aggregate, the maximum credit value set forth below: PRODUCT MAXIMUM CREDIT VALUE TBD The greater of ** dollars ** or ** percent ** of revenues per Year to Supplier under this Agreement, up to a maximum of ** dollars ** in the aggregate per Year. ** This portion has been redacted pursuant to a confidential treatment request. SCHEDULE E
ANNUAL STABILITY TESTING. Patheon and Client will agree in writing on any stability testing to be performed by Patheon on the Products. This agreement will specify the commercial and Product stability protocols applicable to the stability testing and the fees payable by Client for this testing. [NTD: Schedule C should clearly indicate when and/or under what conditions Patheon’s responsibility to perform stability testing will end] Master Manufacturing Services Agreement SCHEDULE D ACTIVE MATERIALS Active Materials Supplier ● ● ● ●
ANNUAL STABILITY TESTING. Patheon and Client will agree in writing on any stability testing to be performed by Patheon on the Products. This agreement will specify the commercial and Product stability protocols applicable to the stability testing and the fees payable by Client for this testing. Release testing will be used for time zero testing as long as batches are placed on stability within […***…] days of completion of release testing. Patheon will be responsible for retest of time zero if delay of placing batches are due to Patheon. Client will be responsible for $[…***…] per sample for any batch delayed more than […***…] days from release testing due to Client. […***…] ***Confidential Treatment Requested SCHEDULE D ACTIVE MATERIALS Active Materials Supplier Pimavanserin tartrate BASF Pharma (Evionnaz) SA and/or its affiliates ACTIVE MATERIALS CREDIT VALUE The Active Materials Credit Value will be as follows: PRODUCT ACTIVE MATERIALS ACTIVE MATERIALS CREDIT VALUE Pimavanserin tablets 17 mg strength Pimavanserin tartrate Client’s actual cost for Active Materials not to exceed $[…***…] per kilogram
ANNUAL STABILITY TESTING. If any annual stability testing on the Product in the Field is required by any Regulatory Authority in the Territory where the Product is commercially sold, Aquestive shall perform such stability testing pursuant to a Statement of Work, and Licensee shall be responsible for all reasonable costs and expenses associated with the performance and maintenance of such stability testing.
ANNUAL STABILITY TESTING. Proposal 130378 NPI and CUSTOMER will agree in writing on any stability testing to be performed by NPI in connection with the Products. The agreement will specify the commercial and Product stability protocols applicable to the stability testing and the fees payable by CUSTOMER for this testing. * * Confidential material redacted and filed separately with the Commission. SCHEDULE D
